Income Tax Expense (Benefit) of Intra-Cellular Therapies, Inc. from 30 Sep 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Intra-Cellular Therapies, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2024 was $317,000, a 171% decline year-over-year.
  • Intra-Cellular Therapies, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2024 was $473,000, a 26% decline year-over-year.
  • Intra-Cellular Therapies, Inc. annual Income Tax Expense (Benefit) for 2024 was $473,000, a 26% decline from 2023.
  • Intra-Cellular Therapies, Inc. annual Income Tax Expense (Benefit) for 2023 was $636,000, a 10500% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Income Tax Expense (Benefit) for 2022 was $6,000, unchanged from 2021.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Intra-Cellular Therapies, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $473,000 $317,000 -$765,000 -171% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $1,238,000 $374,000 +$331,000 +770% 01 Jul 2024 30 Sep 2024 10-K 21 Feb 2025 2024 FY
Q2 2024 $907,000 $57,000 -$78,000 -58% 01 Apr 2024 30 Jun 2024 10-K 21 Feb 2025 2024 FY
Q1 2024 $985,000 $359,000 +$349,000 +3490% 01 Jan 2024 31 Mar 2024 10-K 21 Feb 2025 2024 FY
Q4 2023 $636,000 $448,000 +$448,000 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $188,000 $43,000 +$42,000 +4200% 01 Jul 2023 30 Sep 2023 10-K 21 Feb 2025 2024 FY
Q2 2023 $146,000 $135,000 +$135,000 01 Apr 2023 30 Jun 2023 10-K 21 Feb 2025 2024 FY
Q1 2023 $11,000 $10,000 +$5,000 +100% 01 Jan 2023 31 Mar 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $6,000 $0 -$12,000 -100% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $18,000 $1,000 -$22,000 -96% 01 Jul 2022 30 Sep 2022 10-K 22 Feb 2024 2023 FY
Q2 2022 $40,000 $0 +$24,000 01 Apr 2022 30 Jun 2022 10-K 22 Feb 2024 2023 FY
Q1 2022 $16,000 $5,000 +$10,000 01 Jan 2022 31 Mar 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $6,000 $12,000 +$22,232 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $16,232 $23,000 +$23,000 01 Jul 2021 30 Sep 2021 10-K 01 Mar 2023 2022 FY
Q2 2021 $39,232 $24,000 -$24,000 01 Apr 2021 30 Jun 2021 10-K 01 Mar 2023 2022 FY
Q1 2021 $15,232 $5,000 -$1,719 -52% 01 Jan 2021 31 Mar 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $13,513 $10,232 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $0 +$1,600 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $3,281 01 Jan 2020 31 Mar 2020 10-K 01 Mar 2022 2021 FY
Q2 2019 $1,600 -$3,200 -200% 01 Apr 2019 30 Jun 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $1,600 $0 +$1,058,435 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $1,056,835 $0 +$4,016 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $1,060,851 $1,600 +$1,600 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $1,062,451 $0 -$1,600 -100% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 $1,060,851 $1,058,435 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $4,016 -$836,634 -100% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $0 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $1,600 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q3 2016 $832,618 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q3 2012 $8,230 01 Jul 2012 30 Sep 2012 10-Q 05 Nov 2013 2013 Q3

Intra-Cellular Therapies, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $473,000 -$163,000 -26% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $636,000 +$630,000 +10500% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $6,000 $0 0% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $6,000 -$8,000 -57% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $14,000 +$12,400 +775% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $1,600 $0 0% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $1,600 +$1,062,451 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $1,060,851 -$2,126,524 -200% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $1,065,673 +$1,064,073 +66505% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $1,600 $0 0% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $1,600 -$16,400 -91% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $18,000 -$14,921 -45% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $32,921 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.